FDA.reportPublic FDA data

NDC 67184-0560-01 - Cefazolin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
67184-0560
Requested NDC
67184-0560-01
Package NDCs from labels
67184-0560-1, 67184-0560-2, 67184-0560-01
Manufacturer
Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site)
Effective date
2023-12-18
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefazolin for Injection, USPQilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site)2023-12-18HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
67184-0560-22025-01-30C16284748780-12cef2736-8e0e-d83d-e063-dadaa90ab31fCefazolin for Injection, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67184-0560-1Cefazolin1 in 1 VIALINJECTION, POWDER, FOR SOLUTION17
67184-0560-2Cefazolin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION257

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67184-0560CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [QILU PHARMACEUTICAL CO., LTD.]7Legacy NDC, 2 package rows20231219_e8bd9e95-8af5-416b-b58c-e1dbe3d052ac.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 30 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINApotex Corp.37a626aa-96dc-4c4d-bfbc-be4f328f918b2023-12-15Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.0e8d4462-7642-4296-a605-6c1493e91ffd2023-12-14Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.81d1783a-2baa-4d65-856a-f5ce38d248042023-12-14Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CEFAZOLINCEFAZOLIN SODIUMFresenius Kabi USA, LLCc47c8d14-1eef-40f9-9d11-f0c300b1d4be2023-09-27Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINA-S Medication Solutions8a772acc-726d-40e6-88ee-b6075cbf9b282023-06-23Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINMedical Purchasing Solutions, LLC6673be13-4c74-70b9-e053-2a91aa0a211d2023-06-01Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINMedical Purchasing Solutions, LLC79787707-c84f-f229-e053-2a91aa0a1f162023-05-16Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINProficient Rx LPd24529e3-e2b4-46d6-81ba-b7da745017922022-08-01Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINSandoz Ince58f87fb-a47d-4081-a454-e4e916e2f6292020-09-08Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLIN SODIUMFresenius Kabi USA, LLC47a8928f-708d-418a-829b-36eded96bac02020-06-17Boxed warning, Warnings, Adverse reactionsExact identifier
unii: P380M0454Z

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.